Carnitine for the treatment of autism
Phase 2
Recruiting
- Conditions
- Autistic disorder.Autistic disorderF84.0
- Registration Number
- IRCT20090117001556N136
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
DSM-5 clinical diagnosis of autistic disorder
Children between the ages of 5 and 11 years
Having a minimum score of 12 in irritability
Exclusion Criteria
Presence of any psychiatric disorder
History of allergy to medications used in this research
Presence of any active medical problem such as heart disease
History of uncontrolled seizure
Receiving any psychotropic medications except risperidone during past two weeks prior to the trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of autism. Timepoint: Baseline and weeks 5, and 10. Method of measurement: By Aberrant Behavior Checklist-Community (ABC-C) and Childhood autism rating scale (CARS).
- Secondary Outcome Measures
Name Time Method